Iron lactate induction of pancreatic and endometrial proliferative lesions and a lack of increased tumors in a 104-week carcinogenicity study in F344 rats

  • Imai T
  • Yasuhara K
  • Matsui H
 et al. 
  • 5


    Mendeley users who have this article in their library.
  • 1


    Citations of this article.


Iron lactate has been used as a food additive for iron supplementation. The present study was conducted to determine whether it might have carcinogenic potential. A total of 150 male and 150 female Fischer 344 rats were divided into three groups and fed basal diet containing 0, 1 or 2% of iron lactate for 104 weeks. No iron lactate-induced tumors were observed in any groups, although the incidences of pancreatic acinar cell and endometrial gland hyperplasias were increased in males and females, respectively, in the 2% group. Thus our in vivo animal data indicate that iron lactate lacks carcinogenicity in male and female F344 rats. However, estrogenic effects might be concluded based on the data for endometrial lesions. In a second experiment, an estrogen responsive rat pituitary tumor cell line, MtT/Se, and a human breast cancer cell line, MCF-7, were therefore employed to examine the estrogenic potential of iron lactate with regard to receptor binding affinity and ERE-reporter gene activation. Results in both cases were negative. Further investigations are needed to elucidate the mechanisms of induction of pancreatic and endometrial proliferative lesions by iron lactate. © 2002 Elsevier Science Ltd. All rights reserved.

Author-supplied keywords

  • Carcinogenicity
  • Iron lactate
  • Pancreas
  • Uterus

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • T. Imai

  • K. Yasuhara

  • H. Matsui

  • S. Maruyama

  • N. Fujimoto

  • K. Mitsumori

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free